KEEN, R.; PANTIN, J.; SAVAGE, N.; DAINER, P. M. Treatment of refractory anemia with ring sideroblasts associated with marked thrombocytosis with lenalidomide in a patient testing negative for 5q deletion and JAK2 V617F and MPL W515K/L mutations. Hematology Reports, v. 8, n. 4, 2 Nov. 2016.